Literature DB >> 21731902

Definition, epidemiology and magnitude of alcoholic hepatitis.

Sarpreet Basra1, Bhupinderjit S Anand.   

Abstract

Alcoholic liver disease (ALD) is a major cause of alcohol-related morbidity and mortality. Its presentation ranges from fatty liver to alcoholic hepatitis (AH), cirrhosis, and hepatocellular carcinoma. Although the amount and pattern of alcohol consumption is a well recognized predisposing factor for the development of serious liver pathology, environmental factors and the host's genetic make-up may also play significant roles that have not yet been entirely explored. Continuing alcohol consumption is a major factor that influences the survival of patients with AH. The presence of cirrhosis at presentation or its development on follow up is a major factor determining the outcome in the long run. This chapter deals with the epidemiology and magnitude of ALD in general and AH in particular.

Entities:  

Keywords:  Acute alcoholic hepatitis; Alcoholic hepatitis; Alcoholic liver disease; Disease burden; Epidemiology; Magnitude

Year:  2011        PMID: 21731902      PMCID: PMC3124876          DOI: 10.4254/wjh.v3.i5.108

Source DB:  PubMed          Journal:  World J Hepatol


  59 in total

1.  Non-Alcoholic Steatohepatitis (NASH).

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-12

2.  Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.

Authors:  B L Goodwin; H Xi; R Tejiram; D D Eason; N Ghosh; K L Wright; U Nagarajan; J M Boss; G Blanck
Journal:  Cell Growth Differ       Date:  2001-06

Review 3.  Liver transplantation in alcoholic patients.

Authors:  Patrizia Burra; Michael R Lucey
Journal:  Transpl Int       Date:  2005-05       Impact factor: 3.782

Review 4.  Alcoholic liver disease.

Authors:  Robert S O'Shea; Srinivasan Dasarathy; Arthur J McCullough
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

Review 5.  Alcoholic hepatitis.

Authors:  Michael R Lucey; Philippe Mathurin; Timothy R Morgan
Journal:  N Engl J Med       Date:  2009-06-25       Impact factor: 91.245

6.  Natural history of alcoholic hepatitis. I. The acute disease.

Authors:  M W Lischner; J F Alexander; J T Galambos
Journal:  Am J Dig Dis       Date:  1971-06

7.  Impact of hepatitis C virus infection on the course and outcome of patients with acute alcoholic hepatitis.

Authors:  Ashwani Kumar Singal; Sashidhar Sagi; Yong-Fang Kuo; Steven Weinman
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-03       Impact factor: 2.566

8.  Social epidemiology of chronic liver disease and cirrhosis mortality in the United States, 1935-1997: trends and differentials by ethnicity, socioeconomic status, and alcohol consumption.

Authors:  G K Singh; D L Hoyert
Journal:  Hum Biol       Date:  2000-10       Impact factor: 0.553

9.  Risk factors of fibrosis in alcohol-induced liver disease.

Authors:  Bruno Raynard; Axel Balian; David Fallik; Frédérique Capron; Pierre Bedossa; Jean-Claude Chaput; Sylvie Naveau
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

10.  Changes in drinking patterns among whites, blacks and Hispanics, 1984-1992.

Authors:  R Caetano; L A Kaskutas
Journal:  J Stud Alcohol       Date:  1995-09
View more
  35 in total

Review 1.  The emerging role of mast cells in liver disease.

Authors:  Veronica Jarido; Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Joanne Thomson; Kristen Stephenson; Heather Francis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-04       Impact factor: 4.052

2.  Trihalomethane exposure and biomonitoring for the liver injury indicator, alanine aminotransferase, in the United States population (NHANES 1999-2006).

Authors:  James B Burch; Todd M Everson; Ratanesh K Seth; Michael D Wirth; Saurabh Chatterjee
Journal:  Sci Total Environ       Date:  2015-04-02       Impact factor: 7.963

3.  Pharmacologic Treatment of Alcoholic Hepatitis: Examining Outcomes Based on Disease Severity Stratification.

Authors:  Ryan E Owens; Heather S Snyder; Jennifer D Twilla; Sanjaya K Satapathy
Journal:  J Clin Exp Hepatol       Date:  2016-07-18

Review 4.  Alcoholic hepatitis: current management.

Authors:  Erin K J Spengler; Jeffrey Dunkelberg; Ron Schey
Journal:  Dig Dis Sci       Date:  2014-05-06       Impact factor: 3.199

Review 5.  Fortilin: A Potential Target for the Prevention and Treatment of Human Diseases.

Authors:  Decha Pinkaew; Ken Fujise
Journal:  Adv Clin Chem       Date:  2017-08-07       Impact factor: 5.394

6.  Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study.

Authors:  Adeyinka C Adejumo; George Cholankeril; Umair Iqbal; Eric R Yoo; Brian C Boursiquot; Waldo C Concepcion; Donghee Kim; Aijaz Ahmed
Journal:  Dig Dis Sci       Date:  2019-08-01       Impact factor: 3.199

Review 7.  Focus on alcoholic liver disease: from nosography to treatment.

Authors:  Letiția Adela Maria Streba; Cristin Constantin Vere; Costin Teodor Streba; Marius Eugen Ciurea
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

8.  The Worsening Profile of Alcoholic Hepatitis in the United States.

Authors:  Tuyet A Nguyen; Jonathan P DeShazo; Leroy R Thacker; Puneet Puri; Arun J Sanyal
Journal:  Alcohol Clin Exp Res       Date:  2016-05-05       Impact factor: 3.455

9.  Concomitant Psychiatric and Nonalcohol-Related Substance Use Disorders Among Hospitalized Patients with Alcoholic Liver Disease in the United States.

Authors:  Raxitkumar Jinjuvadia; Chetna Jinjuvadia; Pimpitcha Puangsricharoen; Naga Chalasani; David W Crabb; Suthat Liangpunsakul
Journal:  Alcohol Clin Exp Res       Date:  2018-01-01       Impact factor: 3.455

Review 10.  Clinical impact of alcohol-related cirrhosis in the next decade: estimates based on current epidemiological trends in the United States.

Authors:  John Guirguis; Jagpreet Chhatwal; Jaividhya Dasarathy; John Rivas; David McMichael; Laura E Nagy; Arthur J McCullough; Srinivasan Dasarathy
Journal:  Alcohol Clin Exp Res       Date:  2015-10-25       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.